UnknownPhase 2NCT06019468

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Studying Thymic carcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Principal Investigator
Deping Zhao, MD,PhD
Shanghai Pulmonary Hospital, School of Medicine, Tongji University
Intervention
Envolizumab combined with radiotherapy(other)
Enrollment
25 enrolled
Eligibility
18-75 years · All sexes
Timeline
20232025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06019468 on ClinicalTrials.gov

Other trials for Thymic carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Thymic carcinoma

← Back to all trials